Yuzo Watanabe

2.1k total citations
42 papers, 679 citations indexed

About

Yuzo Watanabe is a scholar working on Nephrology, Hematology and Surgery. According to data from OpenAlex, Yuzo Watanabe has authored 42 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 7 papers in Hematology and 6 papers in Surgery. Recurrent topics in Yuzo Watanabe's work include Dialysis and Renal Disease Management (14 papers), Central Venous Catheters and Hemodialysis (6 papers) and Erythropoietin and Anemia Treatment (5 papers). Yuzo Watanabe is often cited by papers focused on Dialysis and Renal Disease Management (14 papers), Central Venous Catheters and Hemodialysis (6 papers) and Erythropoietin and Anemia Treatment (5 papers). Yuzo Watanabe collaborates with scholars based in Japan, United States and Switzerland. Yuzo Watanabe's co-authors include Yoshiharu Tsubakihara, Ikuto Masakane, Kunitoshi Iseki, Tetsuo Shoji, Nobuo Sakamoto, Nigishi Hotta, Takashi Akiba, Daijo Inaguma, Shigeru Nakai and Atsushi Fukatsu and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Yuzo Watanabe

39 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzo Watanabe Japan 15 380 154 122 79 67 42 679
R. Vanholder Belgium 11 492 1.3× 139 0.9× 137 1.1× 70 0.9× 71 1.1× 14 874
Tung-Po Huang Taiwan 15 316 0.8× 125 0.8× 130 1.1× 86 1.1× 69 1.0× 20 645
Rohini Adhikarla United States 7 425 1.1× 132 0.9× 229 1.9× 41 0.5× 43 0.6× 7 738
R M Hakim United States 9 552 1.5× 176 1.1× 96 0.8× 48 0.6× 86 1.3× 16 779
Masaaki Inaba Japan 12 363 1.0× 106 0.7× 93 0.8× 63 0.8× 38 0.6× 13 588
Szymon Brzόsko Poland 16 238 0.6× 94 0.6× 85 0.7× 40 0.5× 66 1.0× 53 620
B. Canaud France 5 384 1.0× 100 0.6× 164 1.3× 49 0.6× 31 0.5× 7 750
Susanne Schwedler Germany 15 404 1.1× 223 1.4× 69 0.6× 143 1.8× 39 0.6× 22 955
Daijo Inaguma Japan 17 457 1.2× 83 0.5× 77 0.6× 60 0.8× 50 0.7× 95 778
F Gómez-Campderá Spain 12 270 0.7× 110 0.7× 110 0.9× 68 0.9× 21 0.3× 19 546

Countries citing papers authored by Yuzo Watanabe

Since Specialization
Citations

This map shows the geographic impact of Yuzo Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzo Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzo Watanabe more than expected).

Fields of papers citing papers by Yuzo Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzo Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzo Watanabe. The network helps show where Yuzo Watanabe may publish in the future.

Co-authorship network of co-authors of Yuzo Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzo Watanabe. A scholar is included among the top collaborators of Yuzo Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzo Watanabe. Yuzo Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saka, Yosuke, et al.. (2018). Thiamine status in end-stage chronic kidney disease patients: a single-center study. International Urology and Nephrology. 50(10). 1913–1918. 11 indexed citations
2.
Nitta, Kosaku, Ikuto Masakane, Tadashi Tomo, et al.. (2017). Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy. 3(1). 5 indexed citations
3.
Watanabe, Yuzo, Hideki Kawanishi, Kazuyuki Suzuki, et al.. (2015). JapaneseSociety forDialysisTherapyClinicalGuideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions”. Therapeutic Apheresis and Dialysis. 19(S1). 67–92. 76 indexed citations
4.
Akizawa, Tadao, Akira Saitō, Fumitake Gejyo, et al.. (2013). Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study). Therapeutic Apheresis and Dialysis. 18(2). 140–148. 17 indexed citations
5.
Shoji, Tetsuo, Ikuto Masakane, Yuzo Watanabe, Kunitoshi Iseki, & Yoshiharu Tsubakihara. (2011). Elevated Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Predicts Atherosclerotic Cardiovascular Events in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 6(5). 1112–1120. 92 indexed citations
6.
Masakane, Ikuto, Yoshiaki Takemoto, Shigeru Nakai, et al.. (2009). Bacteriological Water Quality in the Central Dialysis Fluid Delivery System from the Survey of the Japanese Society for Dialysis Therapy. Blood Purification. 27(Suppl. 1). 11–16. 18 indexed citations
7.
Suzuki, Masashi, Akira Saitō, Fumitake Gejyo, et al.. (2008). Baseline characteristics and anemia treatment for new hemodialysis patients. Nihon Toseki Igakkai Zasshi. 41(4). 251–254. 4 indexed citations
8.
Masakane, Ikuto, Yoshiharu Tsubakihara, Takashi Akiba, Yuzo Watanabe, & Kunitoshi Iseki. (2008). Bacteriological Qualities of Dialysis Fluid in Japan as of 31 December 2006. Therapeutic Apheresis and Dialysis. 12(6). 457–463. 16 indexed citations
9.
Watanabe, Yuzo. (2004). [Vitamin D supplementation for chronic kidney disease according to the guideline issued by DOQI].. PubMed. 14(5). 778–85. 1 indexed citations
10.
Watanabe, Yuzo. (2001). . Nihon Toseki Igakkai Zasshi. 34(5). 357–364.
11.
Naruse, Tomohiko, et al.. (1998). Identification of risk factors for destructive spondyloarthropathy in hemodialysis patients.. Nihon Toseki Igakkai Zasshi. 31(1). 31–36.
12.
Watanabe, Yuzo, et al.. (1997). Enhancement of Lipid Peroxidation in the Liver of Mice Exposed to Magnetic Fields.. Industrial Health. 35(2). 285–290. 46 indexed citations
13.
Watanabe, Yuzo, et al.. (1996). The Treatment of Chronic Hemodialysis Vascular Access by Directional Atherectomy. Nephron. 74(1). 45–52. 7 indexed citations
14.
Watanabe, Yuzo, et al.. (1996). Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. Journal of Laboratory and Clinical Medicine. 128(6). 568–578. 50 indexed citations
15.
Watanabe, Yuzo, et al.. (1993). Nutritional assessment of hemodialysed patients by urea kinetics model with 5 year follow-up survey.. Journal of Japanese Society for Dialysis Therapy. 26(7). 1237–1244. 1 indexed citations
16.
Watanabe, Yuzo, Yasuhiko Itoh, Futoshi Yoshida, et al.. (1991). Unique Glomerular Lesion with Spontaneous Lipid Deposition in Glomerular Capillary Lumina in the NON Strain of Mice. ˜The œNephron journals/Nephron journals. 58(2). 210–218. 20 indexed citations
17.
Sweezy, Paul M., et al.. (1990). Marxist Views: An Interview with Paul M. Sweezy. Monthly Review. 42(5). 1–1. 1 indexed citations
18.
Yoshida, Futoshi, Seiichi Matsuo, Takeyuki Hiramatsu, et al.. (1989). Glomerular injury induced by antibodies against heparan sulfate proteoglycan (HSPG) derived from PYS 2 cells.. PubMed. 31(2). 135–43. 1 indexed citations
19.
Suzuki, Yuji, et al.. (1989). Effect of erythropoietin on the micronucleus test. Environmental and Molecular Mutagenesis. 13(4). 314–318. 30 indexed citations
20.
Watanabe, Yuzo, Futoshi Yoshida, Atsushi Fukatsu, et al.. (1989). A Case of Nephrotic Syndrome with Glomerular Lipoprotein Deposition with Capillary Ballooning and Mesangiolysis. ˜The œNephron journals/Nephron journals. 51(2). 265–270. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Vanholder Breakdown of academic impact, for papers by Tung-Po Huang Breakdown of academic impact, for papers by Rohini Adhikarla Breakdown of academic impact, for papers by R M Hakim Breakdown of academic impact, for papers by Masaaki Inaba Breakdown of academic impact, for papers by Szymon Brzόsko Breakdown of academic impact, for papers by B. Canaud Breakdown of academic impact, for papers by Susanne Schwedler Breakdown of academic impact, for papers by Daijo Inaguma Breakdown of academic impact, for papers by F Gómez-Campderá
Rankless by CCL
2026